Omadacycline Tosylate and Recombinate
Determining the interaction of Omadacycline Tosylate and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omadacycline Tosylate-Recombinate recombinant
- Omadacycline Tosylate-Recombivax
- Omadacycline Tosylate-Recombivax HB
- Omadacycline Tosylate-Recombivax HB Adult
- Omadacycline Tosylate-Recombivax HB Dialysis Formulation
- Omadacycline Tosylate-Recombivax HB Pediatric/Adolescent
- Recombinate-Omalizumab
- Recombinate-Omalizumab Subcutaneous
- Recombinate-Ombitasvir, Paritaprevir, and Ritonavir
- Recombinate-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Recombinate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Recombinate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets